Cohero Health, a New York-based digital health company, closed a $2m seed funding round.
Backers included Zaffre Investments, Three Leaf Ventures, Swanhill Capital and StartUp Health, via their digital health syndicate on AngelList.
The company plans to use the funds to scale production of its devices to support large customer deployments, and the full-scale commercial launch of its platform.
Led by Melissa Manice, PhD, Cohero Health is advancing connected devices and mobile applications that engage and empower respiratory patients by measuring lung function and tracking adherence.
The company’s proprietary platform include wireless medication inhaler sensors to track patient adherence, anFDA cleared mobile spirometer to measure lung function, mobile applications to engage patients, generate custom reminders and reward compliance, and access to custom data via HIPAA-compliant servers to support patient monitoring.
Cohero Health is a member of StartUp Health, Springboard Enterprises, and Grand Central Tech.